News & Perspective
Drugs & Diseases
CME & Education
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Friday, January 10, 2025
      News & Perspective Drugs & Diseases CME & Education Video Decision Point

      From Medscape Ophthalmology

      Coverage from the

      European Society of Retina Specialists (EURETINA) 2024

      September 19 - 22, 2024; Barcelona, Spain

      September 19 - 22, 2024 Barcelona, Spain

      Conference News

      Medscape Ophthalmology© 

      Popular News From EURETINA 2023

      • Faricimab Efficacy, Safety Hold Up in Real-World Study Faricimab Efficacy, Safety Hold Up in Real-World Study A real-world study of faricimab in neovascular age-related macular degeneration showed visual and anatomical improvement in line with phase 3 trials in treatment-naive and previously treated eyes.
        Medscape Medical News, Oct 12, 2023
      • High-Dose Aflibercept Sustains Outcomes Over 96 Weeks High-Dose Aflibercept Sustains Outcomes Over 96 Weeks The recently approved 8-mg dose of aflibercept has shown sustained improvement in vision and anatomical markers out to 96 weeks, according to updated clinical trial results.
        Medscape Medical News, Oct 12, 2023
      • Eye Specialists Miss Mental Health Issues Linked to AMD Eye Specialists Miss Mental Health Issues Linked to AMD Patients with age-related macular degeneration are known to experience high rates of depression and anxiety, but clinicians often miss the problems, prompting a call for a consensus statement.
        Medscape Medical News, Oct 10, 2023

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Manage Preferences Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      Editions
      English Deutsch Español Français Português
      All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.